About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
CRY - CryoLife| Previous Close | $32.07 | Open | $31.72 |
| Volume | 470.3K | Market Cap | 1.066B |
| Yield | Last Dividend |
| 5 Top Stock Gainers for Friday: Overstoc... | 04/30/21 |
| Overstock.com, Aon, Cryolife, AstraZeneca, Cryolife and Mesoblast are five stock gainers for Friday. | |
| Cardiac Prosthetic Devices Market | Abbo... | 03/23/21 |
| Cardiac Prosthetic Devices Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and re... | |
| CryoLife to Participate in Oppenheimer 3... | 03/09/21 |
| ATLANTA, March 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced... | |
| Vascular Patches Market Anticipated to b... | 03/05/21 |
| Vascular patches are the microporous patch of bio-compatible polyester-urethane patches which are used for vascular surgeries for suturing closure. Ac... | |
| CryoLife Reports Fourth Quarter and Full... | 02/11/21 |
| ATLANTA, Feb. 11, 2021 /PRNewswire/ -- Fourth Quarter and Recent Business Highlights: Achieved total revenues of $67.9 million in the fourth quarter 2... | |
| Specialty Surgical Wound Care Products M... | 01/04/21 |
| SMI has recently published a research report titled, ???Global Specialty Surgical Wound Care Products Market Report 2020???. This report has been prep... | |
| Worldwide Hemostasis and Tissue Sealing ... | 12/30/20 |
| DUBLIN, Dec. 30, 2020 /PRNewswire/ -- The "Hemostasis and Tissue Sealing Agents Market - Global Industry Analysis, Size, Share, Growth, Trends and For... | |
| CryoLife to Host Webcast Discussing PROA... | 11/19/20 |
| ATLANTA, Nov. 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced... | |
| Hemostats Market Leading Players | CryoL... | 11/09/20 |
| Hemostats Market By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Formulat... | |
| Heart Valve Market Is Thriving Worldwide... | 11/06/20 |
| New Study On Heart Valve Market: According to the ???Market Growth Insight???, the Heart Valve market is anticipated to be estimated at USD XX billion... | |
| Top Analyst Upgrades and Downgrades: Bio... | 11/05/20 |
| No summary available. | |
| Top Analyst Upgrades and Downgrades: Bio... | 11/05/20 |
| Thursday's top analyst upgrades and downgrades included Biogen, CryoLife, Honeywell, Microsoft, Ping Identity, Qualcomm, Verizon Communications and We... | |
| CryoLife Reports Third Quarter 2020 Fina... | 11/04/20 |
| ATLANTA, Nov. 4, 2020 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $65.1 million in the third quarter 2020... | |
| Anastomosis Device Market 2020 Size & Sh... | 11/02/20 |
| Global Anastomosis Device Market research report has been organized with most up-to-date insight and analysis to give maximum benefits to the Healthca... | |
| Surgical Sealants and Adhesives Market T... | 10/26/20 |
| Adhesives and sealants are used during surgical procedures to reinforce surgical wounds, repair injured tissues, or even replace common suturing techn... | |
| CryoLife Announces Release Date and Tele... | 10/21/20 |
| ATLANTA, Oct. 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced... | |
| Surgical Sealants and Adhesives Market: ... | 10/20/20 |
| The growth of the surgical sealants and adhesives market is driven by rise in geriatric population and increase in awareness towards the potential ben... | |
| Tissue Regeneration Market Future Scope ... | 10/14/20 |
| The market insights gained through this Tissue Regeneration Market research analysis report facilitates more defined understanding of the market lands... | |
| CryoLife to Participate in Upcoming Virt... | 08/06/20 |
| ATLANTA, Aug. 6, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced ... | |
| CryoLife Reports Second Quarter 2020 Fin... | 07/30/20 |
| ATLANTA, July 30, 2020 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $53.8 million in the second quarter 2... | |
| CryoLife Announces Release Date and Tele... | 07/21/20 |
| ATLANTA, July 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced... | |
| CryoLife Announces Pricing of $100 Milli... | 06/19/20 |
| ATLANTA, June 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focuse... | |
| CryoLife Announces Offering of Convertib... | 06/18/20 |
| ATLANTA , June 18, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY ) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focu... | |
| Insights on the Worldwide Surgical Seala... | 06/11/20 |
| DUBLIN--(BUSINESS WIRE)--The "Surgical Sealant and Adhesives Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAn... | |
| COVID-19 Impact and Recovery Analysis- A... | 06/10/20 |
| Technavio has been monitoring the aortic stent grafts market and it is poised to grow by USD 690.09 million during 2020-2024, progressing at a CAGR of... | |
| Global Structural Heart Disease Treatmen... | 06/03/20 |
| Technavio has been monitoring the global structural heart disease treatment devices market size and it is poised to grow by USD 5.61 billion during 20... | |
| Buy rating | 02/12/21 |
| Needham maintains Buy rating and raises Price Target from $28.00 to $33.00 | |
| Date | 2021-04-29 (AMC) | Est. (EPS/Rev.) | ($0.09)/ 62.98M |
| Actual (EPS/Rev.) | / | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
